{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:45:37Z","timestamp":1790635537199,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.juro.2011.10.144","type":"journal-article","created":{"date-parts":[[2012,1,15]],"date-time":"2012-01-15T16:49:57Z","timestamp":1326646197000},"page":"862-867","source":"Crossref","is-referenced-by-count":63,"title":["Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Gu\u00e9rin Therapy for Bladder Cancer: Results of a Prospective Trial"],"prefix":"10.1097","volume":"187","author":[{"given":"Ashish M.","family":"Kamat","sequence":"first","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rian J.","family":"Dickstein","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Messetti","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosevelt","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna M.","family":"Pretzsch","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela Noguera","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth L.","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanweer","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Department of Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Barton","family":"Grossman","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P.","family":"Dinney","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.10.144_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2011.10.144_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-5347(17)51695-X","article-title":"Superficial bladder cancer: progression and recurrence","volume":"130","author":"Heney","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11934-001-0027-7","article-title":"Immunotherapy for bladder cancer","volume":"2","author":"Kamat","year":"2001","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2011.10.144_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","article-title":"Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?","volume":"166","author":"Herr","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00005392-199909010-00020","article-title":"Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?","volume":"162","author":"Dalbagni","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1078-1439(02)00239-9","article-title":"Is bladder biopsy necessary at three or six months post BCG therapy?","volume":"21","author":"Highshaw","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2011.10.144_bib7","first-page":"117","article-title":"UroVysion multiprobe FISH in urinary cytology","volume":"97","author":"Bubendorf","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.juro.2011.10.144_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.ju.0000149825.83180.a4","article-title":"Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization","volume":"173","author":"Kipp","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.eururo.2007.03.001","article-title":"Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin therapy","volume":"52","author":"Mengual","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1464-410X.2009.08375.x","article-title":"A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy","volume":"104","author":"Whitson","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2011.10.144_bib11","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1002\/ijc.24258","article-title":"The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Gu\u00e9rin therapy","volume":"124","author":"Savic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2011.10.144_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/01.ju.0000136446.37840.0a","article-title":"Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer","volume":"172","author":"O'Donnell","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib15","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.21704","article-title":"Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer","volume":"119","author":"Zellweger","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2011.10.144_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncy.20099","article-title":"Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study","volume":"118","author":"Caraway","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.juro.2011.10.144_bib17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1309\/K5P2-4Y8B-7L5A-FAA9","article-title":"Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings","volume":"116","author":"Bubendorf","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.juro.2011.10.144_bib19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0022-5347(05)64270-X","article-title":"Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer","volume":"168","author":"Sarosdy","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.144_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471105467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471105467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.10.144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T22:23:30Z","timestamp":1651184610000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.10.144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1016\/j.juro.2011.10.144"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.10.144","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14208973.15726084","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}